Facebook
Twitter
Telegram
Report an ErrorBellicum Pharmaceuticals Financial Statements 2011-2024 | BLCM
Annual Financial Statements Bellicum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
8.32 M | 19.6 M | 23.5 M | 62.3 M | 125 M | 260 M | 320 M | 298 M | 620 M | - | - | - |
Shares |
30.8 M | 11.5 M | 5.06 M | 4.68 M | 4.02 M | 3.17 M | 2.7 M | 2.63 M | 2.51 M | - | - | - |
Historical Prices |
0.27 | 1.7 | 4.37 | 9 | 32.1 | 69.5 | 123 | 90.2 | 232 | - | - | - |
Net Income |
-25 M | -9.7 M | -7.72 K | -112 M | -98 M | -91.8 M | -69.2 M | -48.5 M | -84 M | -7.97 M | -6.26 M | - |
Revenue |
1.5 M | 6.2 M | 500 | 7.14 M | 1.12 M | 185 K | 388 K | 282 K | 1.78 M | 1.94 M | 1.47 M | - |
Cost of Revenue |
- | - | - | - | 436 K | 864 K | - | - | - | - | - | - |
Gross Profit |
- | - | 500 | - | - | - | - | 282 K | 1.78 M | 1.94 M | 1.47 M | - |
Operating Income |
-27 M | -24.9 M | -51.7 M | -87.4 M | -95.5 M | -87.4 M | -68.4 M | -49.1 M | -57.8 M | -7.92 M | - | - |
Interest Expense |
- | - | 2.66 M | 4.28 M | 4.2 M | 3.67 M | 1.76 M | 12 K | 1.79 M | 51 K | - | - |
EBITDA |
-27 M | -24.8 M | 3.86 K | -78.9 M | -88.8 M | -83.8 M | -66.1 M | -47.9 M | -14 M | -7.33 M | -6.15 M | - |
Operating Expenses |
28.5 M | 30.6 M | 54.6 K | 94.5 M | 96.6 M | 87.6 M | 68.8 M | 49.4 M | 16.4 M | 9.86 M | 7.74 M | - |
General and Administrative Expenses |
5.72 M | 7.01 M | 15.5 M | 30 M | 25.4 M | 21.9 M | 17.5 M | 15.9 M | 5.4 M | 2.81 M | 1.94 M | - |
All numbers in USD currency
Quarterly Income Statement Bellicum Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
30.9 M | 30.8 M | 30.8 M | 8.61 M | 30.8 M | 30.8 M | 30.8 M | 8.43 M | 10.1 M | 10.1 M | 10 M | 8.32 M | 5.06 M | 5.05 M | 5.04 M | 5.01 M | 4.72 M | 4.61 M | 4.42 M | 4.36 M | 43.3 M | 40.6 M | 33.5 M | 33.3 M | 33.2 M | 33.1 M | 27.3 M | 27.2 M | 27 M | 26.9 M | 26.9 M | 26.9 M | 26.4 M | 26.3 M | 26.3 M | 26.4 M | 2.12 M | 2.12 M | 1.86 M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-763 K | -7.35 M | -8.07 M | - | -7.21 M | -4 M | -7.56 M | - | 1.23 M | -2.2 M | -11.3 M | - | -887 K | -43.2 M | 17.6 M | -29 M | -32 M | -26.9 M | -24.5 M | -27.2 M | -23.8 M | -24.2 M | -22.8 M | -21.9 M | -23.4 M | -24.5 M | -22 M | -19.9 M | -17.7 M | -16.5 M | -15.1 M | -16.8 M | -13.4 M | -10.5 M | -7.76 M | -74.3 M | -4.1 M | -3.28 M | -2.29 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
1 M | - | 8 K | - | 1 M | - | - | - | 5 M | 700 K | - | - | - | - | - | 5.13 M | 103 K | 1.39 M | 516 K | 312 K | 292 K | 362 K | 154 K | -69 K | 126 K | - | 128 K | 81 K | 114 K | 101 K | 92 K | 34 K | 57 K | 84 K | 107 K | 15 K | 660 K | 554 K | 552 K | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 173 K | 30 K | - | 139 K | 150 K | 30 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-773 K | -7.07 M | -8.64 M | - | -7.16 M | -6.54 M | -5.94 M | - | -3.04 M | -7.79 M | -8.94 M | - | -12.3 M | -11.8 M | -14.6 M | -13.9 M | -23.4 M | -26.2 M | -23.9 M | -26.6 M | -23.2 M | -23.6 M | -22.1 M | -19.4 M | -22.7 M | -23.8 M | -21.4 M | -19.5 M | -17.4 M | -16.3 M | -15.2 M | -17 M | -13.6 M | -10.7 M | -7.81 M | -49.4 M | -2.9 M | -3.27 M | -2.28 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | 1 K | 4 K | - | 725 K | 763 K | 985 K | - | 1.08 M | 1.09 M | 1.07 M | - | 1.06 M | 1.04 M | 1 M | - | 1.01 M | 976 K | 721 K | - | 515 K | 486 K | 122 K | - | - | - | - | - | 11 K | 11 K | 16 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -8.64 M | - | -7.16 M | -6.53 M | -5.93 M | - | -2.95 M | -7.72 M | -8.89 M | - | -11.1 M | -10.8 M | -14.1 M | -13.9 M | -18 M | -22.4 M | -22.1 M | -26.6 M | -18.3 M | -20.4 M | -20.7 M | -19.4 M | -20.2 M | -22.2 M | -20.6 M | -19.5 M | -15.8 M | -15.3 M | -14.7 M | -17 M | -12.8 M | -10.3 M | -7.61 M | -49.4 M | -2.41 M | -2.95 M | -2.12 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
1.77 M | 7.07 M | 8.65 M | - | 8.16 M | 6.54 M | 5.94 M | - | 8.03 M | 8.49 M | 8.47 M | - | 12.3 M | 15.5 M | 14.6 M | - | 23.5 M | 27.6 M | 24.4 M | - | 23.5 M | 23.9 M | 22.3 M | - | 22.8 M | 23.8 M | 21.6 M | - | 17.5 M | 16.4 M | 15.3 M | - | 13.7 M | 10.8 M | 7.92 M | - | 3.56 M | 3.83 M | 2.83 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.51 M | 2.26 M | 1.44 M | - | 1.32 M | 1.45 M | 1.45 M | - | 1.68 M | 1.76 M | 2.01 M | - | 4.16 M | 3.76 M | 4.17 M | - | 9.21 M | 7.52 M | 7.54 M | - | 6.97 M | 5.37 M | 5.69 M | - | 4.58 M | 5.49 M | 5.93 M | - | 4.25 M | 4.18 M | 4.28 M | - | 3.88 M | 2.78 M | 2.2 M | - | 1.3 M | 592 K | 440 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency